Katie Moisse is contributing editor and former news editor at The Transmitter. She teaches science communication at McMaster University in Hamilton, Ontario, Canada. She has a Ph.D. in neuropathology from the University of Western Ontario and an M.S. in journalism from Columbia University.
Katie Moisse
Contributing editor
The Transmitter
From this contributor
Frameshift: How Caitlin Vander Weele made science communication her business
Her favorite part of research was talking about it. So she left academia and turned that passion into a successful company.
Frameshift: How Caitlin Vander Weele made science communication her business
By
Katie Moisse
19 March 2026 | 6 min read
Frameshift: Raphe Bernier followed his heart out of academia, then made his way back again
After a clinical research career, an interlude at Apple and four months in early retirement, Raphe Bernier found joy in teaching.
Frameshift: Raphe Bernier followed his heart out of academia, then made his way back again
By
Katie Moisse
20 February 2026 | 8 min read
Frameshift: At a biotech firm, Ubadah Sabbagh embraces the expansive world outside academia
As chief of staff at Arcadia, Ubadah Sabbagh gets to do science while also pushing the boundaries of how science gets done.
Frameshift: At a biotech firm, Ubadah Sabbagh embraces the expansive world outside academia
By
Katie Moisse
20 January 2026 | 7 min read
Frameshift: Shari Wiseman reflects on her pivot from science to publishing
As chief editor of Nature Neuroscience, Wiseman applies critical-thinking skills she learned in the lab to manage the journal’s day-to-day operations.
Frameshift: Shari Wiseman reflects on her pivot from science to publishing
By
Katie Moisse
15 December 2025 | 7 min read
The spectrum goes multidimensional in search of autism subtypes
Grouping people with autism based on shared features, genetics and co-occurring conditions may improve clinical trial outcomes, researchers say.
The spectrum goes multidimensional in search of autism subtypes
By
Katie Moisse
14 August 2025 | 7 min read
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
By
Angie Voyles Askham
17 April 2026 | 8 min read
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
By
Charles Q. Choi
16 April 2026 | 4 min read
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
By
Helena Kudiabor
15 April 2026 | 4 min read